Skip to content
Riskpilot
← Back to search
Sign in
Get full access
CuraCell TX AB
AB
Active
Org 5592808546
Nanna Svartz Väg 4, 171 65
Solna
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2020 · 5 years old
5 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
CuraCell TX AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
1M
2024
0M
2025
EBITDA
SEK millions
0M
-10M
-20M
-30M
-40M
0M
2021
-1M
-100%
2022
-5M
-400%
2023
-7M
-40%
2024
-32M
-357%
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
0
0
0
1 367
45
Staff expenses
—
—
−378
−3 163
−5 450
EBITDA
−6
−675
−5 304
−7 413
−31 912
Depreciation & amort.
−0
—
−9
−74
−152
EBIT
−6
−675
−5 313
−7 487
−32 064
Net financials
−2
—
−0
375
−2
Profit before tax
−8
−675
−5 313
−7 112
−32 065
Tax
−0
—
—
—
—
Net profit
−8
−675
−5 313
−7 112
−32 065
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
11 996
29 679
31 689
37 334
49 388
Equity
2 017
1 342
26 029
28 892
6 831
Long-term debt
0
28 051
4 439
6 982
39 079
Short-term debt
9 979
286
1 221
1 460
3 478
Total debt
9 979
28 337
5 660
8 442
42 556
Financial ratios
5-year trend
EBITDA margin
-70916.3%
This company
15.8%
Market median
-448937% vs market
2021
2025
Equity ratio
13.8%
This company
38.2%
Market median
-64% vs market
2021
2025
Return on equity
-469.4%
This company
18.4%
Market median
-2651% vs market
2021
2025
Net profit margin
-71256.5%
This company
8.1%
Market median
-879810% vs market
2021
2025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2021
2025
Debt / equity
6.23×
This company
0.62×
Market median
-905% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-11-01 – 2021-12-31
View
PDF
More on CuraCell TX AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
